HPC.AX ASX
The Hydration Pharmaceuticals Company Limited
1W: +0.0%
1M: +0.0%
3M: -25.0%
YTD: -40.0%
1Y: -66.7%
3Y: -93.0%
A$0.00 ($0.00)
+0.00 (+0.00%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Income Trends
Revenue
$3M
-20.2% ▼
5Y CAGR: -7.4%
Gross Profit
-$27K
-101.7% ▼
Operating Income
-$3M
+22.4% ▲
Net Income
-$3M
-211.0% ▼
EPS (Diluted)
$-0.01
-177.0% ▼
EBITDA
-$3M
+16.7% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6M | $9M | $10M | $3M | $3M |
| YoY Growth | +63.1% | +48.5% | +10.3% | -68.1% | -20.2% |
| Cost of Revenue | $3M | $4M | $5M | $2M | $3M |
| Gross Profit | $3M | $5M | $5M | $2M | -$27K |
| Gross Margin | 45.5% | 51.6% | 53.7% | 50.6% | -1.1% |
| R&D Expenses | $0 | $0 | $0 | $0 | $0 |
| SG&A Expenses | $9M | $15M | $13M | $6M | $3M |
| Operating Expenses | $10M | $15M | $9M | $6M | $3M |
| Operating Income | -$7M | -$11M | -$7M | -$4M | -$3M |
| Operating Margin | -122.3% | -117.6% | -68.4% | -131.0% | -127.3% |
| Interest Expense | $4M | $91K | $643K | $2M | $75 |
| Income Before Tax | -$9M | -$11M | -$8M | -$6M | -$3M |
| Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$9M | -$11M | -$8M | $3M | -$3M |
| Net Margin | -146.3% | -116.6% | -80.7% | 83.2% | -115.7% |
| EPS (Diluted) | $-0.12 | $-0.07 | $-0.04 | $0.01 | $-0.01 |
| EBITDA | -$6M | -$11M | -$7M | -$4M | -$3M |
| Shares Outstanding | 76M | 163M | 195M | 267M | 387M |